Article ID Journal Published Year Pages File Type
9261996 Best Practice & Research Clinical Rheumatology 2005 20 Pages PDF
Abstract
RA patients and their friends and families incur the majority of costs associated with early RA. Many patients are not able to continue to work at the same level as they would have anticipated had they not developed RA. Later on, society bears an increased load, especially in patients with higher levels of disability; this results from major social care costs and interventions such as surgery. However, the evidence favouring expensive biological therapies, even in early RA, is likely to turn this analysis on its head in the near future.
Related Topics
Health Sciences Medicine and Dentistry Immunology, Allergology and Rheumatology
Authors
, , ,